16 November 2021
Top global hires for large-cap, mid-cap and public companies
Search Highlights
Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
CEO/ C-suite/ Board
| Function | Focus area | Location |
|---|---|---|
| CEO (US) | In-vitro diagnostics (publicly listed) | Europe |
| Chief Commercial Officer | Cell & gene therapy (publicly listed) | Europe |
| Chief Medical Officer | Biotech (publicly listed) | US |
| Chief Technical Officer | Gene therapy (large cap) | US, Europe |
| Chief Human Resources Officer | Gene therapy (publicly listed) | Europe |
| Chief Scientific Officer | Specialty pharma (publicly listed) | Europe |
| Chief Scientific Officer (US) | Biotech (publicly listed) | Canada |
| Chief Financial Officer | Biotech (publicly listed) | Europe |
| Chief Business Officer | Biopharma (publicly listed) | US |
| Board Director | Biotech (publicly listed) | Europe |
| Board Director | Biotech (publicly listed) | US |
| Board Director (US) | Biotech (publicly listed) | Europe |
| Board Director & Chair Audit | Biopharma (publicly listed) | US |
Commercial / Functional / Strategic Leadership
| Function | Focus area | Location |
|---|---|---|
| VP Commercial Strategy & Enablement | Diagnostics (large-cap) | US |
| Head of Human Resources | Biotech (publicly listed) | Europe |
| Area & Neurology Head France | Biopharma (large-cap) | Europe |
| Head Market Access & Government Affairs Benelux | Medical devices (large-cap) | US |
| Global Unit Head Business Partnering (US) | Speciality pharma (mid-cap) | Europe |
| Global Head, Scientific and Medical Communications | Contract research organisation (large-cap) | US |
| General Manager Italy | Medical devices & instruments (large-cap) | Europe |
| Swine Market Unit Director | Animal health pharma (top 5 global) | France |
| Director of HR Oncology France | Pharma (top 10 global) | Europe |
R&D/ Medical/ Technical
| Function | Focus area | Location |
|---|---|---|
| VP Global CMC Regulatory Affairs (US) | Biopharma (publicly listed) | Europe |
| VP, Translational | Biopharma (publicly listed) | US |
| Head of Downstream Processing | Health ingredients (publicly listed) | Europe |
| Head of Manufacturing | Pharma (publicly listed) | Europe |
| Early Development Leader | Biopharma (large-cap) | Europe |
| Medical Director Haemophilia | Specialty pharma (mid-cap) | Europe |
| Director Clinical Development Oncology | Pharma (large-cap) | Europe |
| Global Regulatory Affairs Lead | Vaccines (publicly listed) | Europe |
| Global R&D Director | Surgical products and solutions (mid-cap) | Europe |
| Global Head of Quality | Pharma (family-owned mid-cap) | Europe |
Related
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023
-
Press Releases
Coulter Partners places Vice President of Intellectual Property at Amphista Therapeutics
09 March 2023
